These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 31180909)
1. Tumor Mutation Burden and Checkpoint Immunotherapy Markers in NUT Midline Carcinoma. He M; Chernock R; Zhou S; Gondim M; Dehner LP; Pfeifer JD Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):495-500. PubMed ID: 31180909 [TBL] [Abstract][Full Text] [Related]
2. Tumor mutation burden and checkpoint immunotherapy markers in primary and metastatic synovial sarcoma. He M; Abro B; Kaushal M; Chen L; Chen T; Gondim M; Yan W; Neidich J; Dehner LP; Pfeifer JD Hum Pathol; 2020 Jun; 100():15-23. PubMed ID: 32387103 [TBL] [Abstract][Full Text] [Related]
3. Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma. Xie XH; Wang LQ; Qin YY; Lin XQ; Xie ZH; Liu M; Zhang JX; Ouyang M; Liu J; Gu YY; Li SY; Zhou CZ Orphanet J Rare Dis; 2020 Jul; 15(1):183. PubMed ID: 32650830 [TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case. Chen M; Chen X; Zhang Y; Wang W; Jiang L J Cancer Res Clin Oncol; 2023 Aug; 149(9):6361-6370. PubMed ID: 36752907 [TBL] [Abstract][Full Text] [Related]
5. Tumor mutation burden, DNA mismatch repair status and checkpoint immunotherapy markers in primary and relapsed malignant rhabdoid tumors. Abro B; Kaushal M; Chen L; Wu R; Dehner LP; Pfeifer JD; He M Pathol Res Pract; 2019 Jun; 215(6):152395. PubMed ID: 31047727 [TBL] [Abstract][Full Text] [Related]
6. Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion. Agaimy A; Haller F; Renner A; Niedermeyer J; Hartmann A; French CA Am J Surg Pathol; 2022 Feb; 46(2):281-288. PubMed ID: 34232599 [TBL] [Abstract][Full Text] [Related]
7. Nuclear Protein in Testis (NUT) Carcinoma: A Comprehensive Immunohistochemical Analysis of 57 Cases With Consideration of Interpretation and Pitfall Recognition. Farooq A; Kerper AL; Boland JM; Lo YC Arch Pathol Lab Med; 2024 Aug; 148(8):898-904. PubMed ID: 38059551 [TBL] [Abstract][Full Text] [Related]
8. Programmed Death Ligand 1 Expression and Related Markers in Pleuropulmonary Blastoma. Alipour Z; Schultz KAP; Chen L; Harris AK; Gonzalez IA; Pfeifer J; Hill DA; He M; Dehner LP Pediatr Dev Pathol; 2021; 24(6):523-530. PubMed ID: 34266329 [TBL] [Abstract][Full Text] [Related]
9. [Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract]. Fang W; French CA; Cameron MJ; Han YD; Liu HG Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):519-24. PubMed ID: 23157742 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract. Fang W; French CA; Cameron MJ; Han Y; Liu H Int J Surg Pathol; 2013 Apr; 21(2):102-10. PubMed ID: 22777717 [TBL] [Abstract][Full Text] [Related]
11. NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue. Suzuki S; Kurabe N; Ohnishi I; Yasuda K; Aoshima Y; Naito M; Tanioka F; Sugimura H Pathol Res Pract; 2015 May; 211(5):404-8. PubMed ID: 25466466 [TBL] [Abstract][Full Text] [Related]
12. A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses. Suzuki S; Kurabe N; Minato H; Ohkubo A; Ohnishi I; Tanioka F; Sugimura H Pathol Res Pract; 2014 Jun; 210(6):383-8. PubMed ID: 24655834 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive genetic profiling of six pulmonary nuclear protein in testis carcinomas with a novel micropapillary histological subtype in two cases. Chen M; Yang J; Lv L; Li Y; Tang Y; Liu W; Wang W; Jiang L Hum Pathol; 2021 Sep; 115():56-66. PubMed ID: 33713695 [TBL] [Abstract][Full Text] [Related]
14. NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion. Chen M; Zhao S; Liang Z; Wang W; Zhou P; Jiang L Virchows Arch; 2022 Apr; 480(4):887-897. PubMed ID: 35064291 [TBL] [Abstract][Full Text] [Related]
15. [A Case Report of Primary Pulmonary NUT Carcinoma and Literature Review]. Liu X; Li Y; Yu M; Zhou L Zhongguo Fei Ai Za Zhi; 2021 Jan; 24(1):63-68. PubMed ID: 33478193 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Haack H; Johnson LA; Fry CJ; Crosby K; Polakiewicz RD; Stelow EB; Hong SM; Schwartz BE; Cameron MJ; Rubin MA; Chang MC; Aster JC; French CA Am J Surg Pathol; 2009 Jul; 33(7):984-91. PubMed ID: 19363441 [TBL] [Abstract][Full Text] [Related]
17. Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing. Kim HS; Cha H; Kim J; Park WY; Choi YL; Sun JM; Ahn JS; Ahn MJ; Park K; Lee SH Eur J Cancer; 2019 Oct; 120():65-74. PubMed ID: 31493723 [TBL] [Abstract][Full Text] [Related]
18. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis. Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993 [TBL] [Abstract][Full Text] [Related]
19. Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients. Bishop JA; French CA; Ali SZ Cancer Cytopathol; 2016 Dec; 124(12):901-908. PubMed ID: 27400194 [TBL] [Abstract][Full Text] [Related]
20. Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family. Chien YW; Hsieh TH; Chu PY; Hsieh SM; Liu ML; Lee JC; Liu YR; Ku JW; Kao YC Genes Chromosomes Cancer; 2019 Nov; 58(11):809-814. PubMed ID: 31334571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]